Results 31 to 40 of about 895,257 (215)

Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review

Infection and Drug Resistance, 2021
Mihret Tilahun, Yeshimebet kassa, Alemu Gedefie, Melaku Ashagire Department of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, EthiopiaCorrespondence: Mihret TilahunDepartment of Medical Laboratory Science ...
Tilahun M, kassa Y, Gedefie A, Ashagire M   +3 more
doaj  

Carbapenem-resistant genes primer sets.

, 2023
BackgroundCarbapenem-resistant Enterobacteriaceae (CRE) and Extended-spectrum beta-lactamase (ESBL) production among Gram-negative Enterobacteriaceae is an increasing global challenge due to the high morbidity and mortality associated with their ...
Frank Twum Aboagye (17304867), Alex Owusu-Ofori (5931680), Isaac Owusu-Frimpong (11047490), James Sampah (17304864)   +3 more
core   +1 more source

Frequency of and risk factors for carbapenem-resistant Enterobacteriaceae

Journal of Medical Microbiology, 2021
Introduction. Carbapenem-resistant Enterobacteriaceae (CRE) are an urgent threat in the USA and are associated with adverse clinical and economic outcomes. Several studies have evaluated risk factors for acquiring CRE versus carbapenem-susceptible
Katie E. Barber, Jamie L. Wagner, Rachel C. Larry, Kayla R. Stover   +3 more
openaire   +2 more sources

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Brazilian Journal of Infectious Diseases, 2017
This study evaluated the in vitro activity of ceftolozane-tazobactam and comparator agents tested against Latin American isolates of Enterobacteriaceae and Pseudomonas aeruginosa from patients with health care-associated infections.
Michael A. Pfaller, Dee Shortridge, Helio S. Sader, Ana Gales, Mariana Castanheira, Robert K. Flamm   +5 more
doaj   +1 more source

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae

New England Journal of Medicine, 2019
Plazomicin for Severe Resistant Infection This report compared plazomicin with colistin for the treatment of severe (bloodstream or pneumonia) infection with carbapenem-resistant Enterobacteriaceae...
McKinnell, J.A., Dwyer, J.P., Talbot, G.H., Connolly, L.E., Friedland, I., Smith, A., Jubb, A.M., Serio, A.W., Krause, K.M., Daikos, G.L.   +9 more
openaire   +3 more sources

Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing Enterobacteriaceae Colonization and Subsequent Infection

Microbiology Spectrum, 2022
Gastrointestinal colonization with carbapenem-resistant Enterobacteriaceae (CRE) is always a prerequisite for the development of translocated infections.
Wenli Yuan, Jiali Xu, Lin Guo, Yonghong Chen, Jinyi Gu, Huan Zhang, Chenghang Yang, Qiuping Yang, Shuwen Deng, Longlong Zhang, Qiongfang Deng, Zi Wang, Bin Ling, Deyao Deng   +13 more
doaj   +1 more source

Antibacterial Activity of Alchornea cordifolia (Christmas bush) Leaves Extract on Carbapenem Resistant Enterobacteriaceae Causing Multi-drug Resistant Systemic Infections [PDF]

, 2020
Carbapenems have been used for the treatment of systemic infections caused by Enterobacteriaceae. However, recent studies suggested that some Enterobacteriaceae are producing carbapenemases, which has limited the treatment options for carbapenem ...
Azumah, Bright Kojo, Boateng, David, Hackman, Henry Kwadwo, Nwosu, Blessing, Appenteng, Mark, Arhin, Reuben Essel   +5 more
core   +1 more source

Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis

Brazilian Journal of Infectious Diseases, 2015
In recent years, carbapenem-resistant Enterobacteriaceae has become endemic in many countries. Because of limited treatment options, the abandoned “old antibiotics”, polymyxins, have been reintroduced to the clinic.
Wentao Ni, Xuejiu Cai, Chuanqi Wei, Xiuzhen Di, Junchang Cui, Rui Wang, Youning Liu   +6 more
doaj   +1 more source

Detection of Klebsiella pneumoniae Carbapenemase (KPC) Producing Enterobacteriaceae Isolates from Various Clinical Samples in a Rural Health Setup

Journal of Pure and Applied Microbiology, 2020
Carbapenem resistance is increasing and emerging as a public health threat. The Indian subcontinent serves as a reservoir for all 3 types of carbapenemases: KPC, OXA-181 and NDM. The present study was done to determine the antibiotic resistance pattern
Arveen Sokhi, Priti Agarwal, Megha Maheshwari, Anita Chakravarti   +3 more
doaj   +1 more source

Activities of imipenem-relebactam combination against carbapenem-nonsusceptible Enterobacteriaceae in Taiwan

Journal of Microbiology, Immunology and Infection, 2022
Background: Imipenem-relebactam is a new β-lactam and β-lactamase inhibitor combination to treat carbapenem-resistant gram-negative bacteria infections. However, difference in carbapenem resistant mechanisms existed with geographic variations. Objective:
Tsung-Ying Yang, Ya-Ju Hsieh, Li-Ting Kao, Guan Hong Liu, Shao-Hsuan Lian, Liang-Chun Wang, I-Ling Lin, Hsian-Yu Wang, Sung-Pin Tseng, Po-Liang Lu   +9 more
doaj   +1 more source